Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope

Pharmacological management has advanced considerably since the 2015 British Society for Rheumatology axial spondyloarthritis (axSpA) guideline to incorporate new classes of biologic DMARDs (bDMARDs, including biosimilars), targeted synthetic DMARDs (tsDMARDs) and treatment strategies such as drug ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Sizheng Steven, Harrison, Stephanie R, Chan, Antoni, Clarke, Nick, Davis, Charlotte, Eddison, Joe, Gregory, William J, Jones, Gareth T, Marzo-Ortega, Helena, Murphy, Daniel J, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan, Thompson, Ben, Webb, Dale, Yates, Max, Gaffney, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183299/
https://www.ncbi.nlm.nih.gov/pubmed/37197377
http://dx.doi.org/10.1093/rap/rkad039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183299/
https://www.ncbi.nlm.nih.gov/pubmed/37197377
http://dx.doi.org/10.1093/rap/rkad039

Ejemplares similares